Evidence map›Paper›PMID 22440900›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Inhibition of integrin α2β1 ameliorates glomerular injury.

Corina M Borza, Yan Su, Xiwu Chen, Ling Yu, Stacey Mont, Sergei Chetyrkin, Paul Voziyan, Billy G Hudson, Paul C Billings, Hyunil Jo and 5 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 68 citations in OpenAlex.

  1. Treatment Approaches for Alport Syndrome.Journal of the American Society of Nephrology : JASN · 2026
    Review
  2. Article
  3. Article
  4. Integrins in the kidney - beyond the matrix.Nature reviews. Nephrology · 2025
    Review
  5. Review
  6. Mice with aAmerican journal of physiology. Renal physiology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Nephrin Signaling Results in IntegrinJournal of the American Society of Nephrology : JASN · 2019
    Article
  19. Review
  20. The laminin binding α3 and α6 integrins cooperate to promote epithelial cell adhesion and growth.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Corina M BorzaDepartments of Medicine and Cancer Biology, Division of Nephrology and Hypertension, Vanderbilt University, Medical Center North, Nashville, TN 37232, USA.
Yan Su
Xiwu Chen
Ling Yu
Stacey Mont
Sergei Chetyrkin
Paul Voziyan
Billy G Hudson
Paul C Billings
Hyunil Jo
Joel S Bennett
William F Degrado
Beate Eckes
Roy Zent
Ambra Pozzi
University of Pennsylvania · USCentre for Cancer Biology · AUUniversity of Cologne · DEVanderbilt University Medical Center · US

Funding

Subcellular Mechanisms pf Platelet ActivationP01HL040387 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BENNETT, JOEL S. · 1988 to 2018
$35.5M
TYPE IV COLLAGEN, LAMININS, AND INTEGRINS IN NORMAL AND DISEASED GLOMERULIP01DK065123 · NIDDK · VANDERBILT UNIVERSITY · PI HUDSON, BILLY GERALD · 2003 to 2012
$12.9M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
Vanderbilt O'Brien Mouse Kidney Physiology and Disease CenterP30DK079341 · NIDDK · VANDERBILT UNIVERSITY · PI HARRIS, RAYMOND C. · 2008 to 2013
$4.4M
Betal Integrin and Renal TubulogenesisR01DK075594 · NIDDK · VANDERBILT UNIVERSITY · PI ZENT, ROY · 2008 to 2015
$2.6M
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2R01DK083187 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SANDERS, CHARLES R, ZENT, ROY · 2010 to 2013
$1.3M
NHLBI NIH HHS P01 HL040387NIDDK NIH HHS 2P01DK065123NIDDK NIH HHS DK075594NIDDK NIH HHS DK083187NIDDK NIH HHS P01 DK065123NIDDK NIH HHS P30 DK079341NIDDK NIH HHS P30DK79341-01NIDDK NIH HHS R01 DK075594NIDDK NIH HHS R01 DK083187NIGMS NIH HHS R25 GM062459
6 · The paper itself

Abstract

Mesangial cells and podocytes express integrins α1β1 and α2β1, which are the two major collagen receptors that regulate multiple cellular functions, including extracellular matrix homeostasis. Integrin α1β1 protects from glomerular injury by negatively regulating collagen production, but the role of integrin α2β1 in renal injury is unclear. Here, we subjected wild-type and integrin α2-null mice to injury with adriamycin or partial renal ablation. In both of these models, integrin α2-null mice developed significantly less proteinuria and glomerulosclerosis. In addition, selective pharmacological inhibition of integrin α2β1 significantly reduced adriamycin-induced proteinuria, glomerular injury, and collagen deposition in wild-type mice. This inhibitor significantly reduced collagen synthesis in wild-type, but not integrin α2-null, mesangial cells in vitro, demonstrating that its effects are integrin α2β1-dependent. Taken together, these results indicate that integrin α2β1 contributes to glomerular injury by positively regulating collagen synthesis and suggest that its inhibition may be a promising strategy to reduce glomerular injury and proteinuria.

Indexed as

Acute Kidney InjuryAlbuminuriaAnalysis of VarianceAnimalsBlotting, WesternDisease Models, AnimalDoxorubicinEnzyme-Linked Immunosorbent AssayFlow CytometryImmunohistochemistryIntegrin alpha2beta1Kidney Function TestsKidney GlomerulusMaleMesangial CellsMiceDoxorubicinIntegrin alpha2beta1Receptors, Collagen

Identifiers

PMID22440900
PMCPMC3358756
OpenAlexW2157653193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.